Your browser doesn't support javascript.
loading
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine.
Capper, David; von Deimling, Andreas; Brandes, Alba A; Carpentier, Antoine F; Kesari, Santosh; Sepulveda-Sanchez, Juan M; Wheeler, Helen R; Chinot, Olivier; Cher, Lawrence; Steinbach, Joachim P; Specenier, Pol; Rodon, Jordi; Cleverly, Ann; Smith, Claire; Gueorguieva, Ivelina; Miles, Colin; Guba, Susan C; Desaiah, Durisala; Estrem, Shawn T; Lahn, Michael M; Wick, Wolfgang.
Affiliation
  • Capper D; Department of Neuropathology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. david.capper@charite.de.
  • von Deimling A; Department of Neuropathology, University Hospital Heidelberg and Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. andreas.vondeimling@med.uni-heidelberg.de.
  • Brandes AA; Medical Oncology Department, Bellaria-Maggiore Hospitals, Azienda USL-IRCCS Institute of Neurological Sciences, 40139 Bologna, Italy. a.brandes@ausl.bo.it.
  • Carpentier AF; Assistance Publique-Hôpitaux de Paris (AP-HP) & Paris 13 University, Hôpital Avicenne, Service de Neurologie, 93009 Bobigny, France. antoine.carpentier@avc.aphp.fr.
  • Kesari S; UC San Diego Health System, La Jolla, CA 92103, USA. kesaris@jwci.org.
  • Sepulveda-Sanchez JM; Hospital Universitario 12 de Octubre, 28041 Madrid, Spain. jmsepulveda.hdoc@salud.madrid.org.
  • Wheeler HR; Department of Oncology, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia. hrwheeler@optusnet.com.au.
  • Chinot O; CHU Hôpital De La Timone, Rue Saint Pierre, 13385 Marseille, France. olivier.chinot@ap-hm.fr.
  • Cher L; Austin Hospital, Heidelberg, VIC 3084, Australia. lmcher@mac.com.
  • Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, 60590 Frankfurt, Germany. Joachim.steinbach@med.uni-frankfurt.de.
  • Specenier P; Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium. pol.specenier@uza.be.
  • Rodon J; Medical Oncology, Vall d'Hebron University Hospital, Calle Natzaret, 115-117, 08035 Barcelona, Spain. jrodon@vhebron.net.
  • Cleverly A; Eli Lilly and Company, Erl Wood Manor, Windlesham GU20 6PH, UK. cleverly_ann_louise@lilly.com.
  • Smith C; Eli Lilly and Company, Erl Wood Manor, Windlesham GU20 6PH, UK. csmith@lilly.com.
  • Gueorguieva I; Eli Lilly and Company, Erl Wood Manor, Windlesham GU20 6PH, UK. gueorguieva_ivelina@lilly.com.
  • Miles C; Eli Lilly and Company, Erl Wood Manor, Windlesham GU20 6PH, UK. miles_colin_p@lilly.com.
  • Guba SC; Eli Lilly and Company, Indianapolis, IN 46285, USA. guba_susan_c@lilly.com.
  • Desaiah D; Eli Lilly and Company, Indianapolis, IN 46285, USA. desaiah_durisala@lilly.com.
  • Estrem ST; Eli Lilly and Company, Indianapolis, IN 46285, USA. estrem_shawn_t@lilly.com.
  • Lahn MM; Eli Lilly and Company, Indianapolis, IN 46285, USA. michalahn@aol.com.
  • Wick W; Department of Neurology, University Hospital Heidelberg, 69120 Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de.
Int J Mol Sci ; 18(5)2017 May 06.
Article in En | MEDLINE | ID: mdl-28481241

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Quinolines / Biomarkers, Tumor / Glioblastoma / Lomustine / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Int J Mol Sci Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Quinolines / Biomarkers, Tumor / Glioblastoma / Lomustine / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Int J Mol Sci Year: 2017 Document type: Article Affiliation country: